Mediconomics
Mediconomics is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Clinical study to evaluate the safety and tolerability of long-term treatment with Lecicarbon® in patients with chronic constipation
Sponsor Athenstaedt GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irritable bowel syndrome (IBS-D) and patients with mixed-type irritable bowel syndrome (IBS-M)
Sponsor REPHA GmbH Biologische Arzneimittel
- Start (EU)
- Latest update
- Estimated end
- Not reported
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irritable bowel syndrome (IBS-D)
Sponsor REPHA GmbH Biologische Arzneimittel
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in the gastrointestinal tract, flatulence and bloating.
Sponsor CGBS GbR
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Mediconomics?
The 2026-10-09 snapshot links Mediconomics to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Electronic data capture, Medical writing, among 12 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Mediconomics?
The most frequently recorded therapeutic areas are Gastroenterology. Recorded phases include Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Mediconomics conducted?
The linked trials record locations in 1 country, including Germany. These are trial locations, not confirmed office locations or countries where Mediconomics delivered services.
What can this page tell me about Mediconomics's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Mediconomics. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Mediconomics GmbH